TRAX
TRAX insider receives 42,500 shares in stock awards
STONE BENJAMIN reported 42,500 shares of Common Stock (derivative) in First Tracks Biotherapeutics, Inc. as grants or awards dated 2026-11-01. The Form 4 was disclosed on Nov 3, 2026. These were stock awards, not open-market purchases.